(Q42275611)

19 October 2017

title

Cytomegalovirus DNAemia detected with real-time polymerase chain reaction in hematopoietic stem cell transplant patients (English)

1 reference

real-time polymerase chain reaction

19 October 2017

main subject

1 reference

Deniz Goren Sahin

1

1 reference

19 October 2017

Eren Gunduz

2

1 reference

19 October 2017

Nilgun Kasifoglu

3

1 reference

19 October 2017

Olga Meltem Akay

4

1 reference

19 October 2017

Tercan Us

5

1 reference

19 October 2017

Zafer Gulbas

6

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 August 2013

1 reference

19 October 2017

1 reference

19 October 2017

volume

30

1 reference

19 October 2017

issue

8

1 reference

19 October 2017

page(s)

784-791

1 reference

Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Differences in Cytomegalovirus Replication Quantified Using Quantitative Polymerase Chain Reaction and Antigenemia After Allogeneic Stem Cell Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Quantification of DNA in plasma by an automated real-time PCR assay (cytomegalovirus PCR kit) for surveillance of active cytomegalovirus infection and guidance of preemptive therapy for allogeneic hematopoietic stem cell transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Cytomegalovirus in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Cytomegalovirus reactivation in pediatric hemopoietic progenitors transplant: a retrospective study on the risk factors and the efficacy of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Cytomegalovirus (CMV) infections in children undergoing hematopoetic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Surveillance of active human cytomegalovirus infection in hematopoietic stem cell transplantation (HLA sibling identical donor): search for optimal cutoff value by real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Management of cytomegalovirus infection in haemopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Recent advances in the therapy and prevention of CMV infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Increased incidence of CMV infection after allogeneic bone marrow transplantation from unrelated donors but doubts about an increase in CMV-associated disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Cytomegalovirus infection in children who underwent hematopoietic stem cell transplantation at a single center: a retrospective study of the risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 antigenemia assay in monitoring patients after allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-013-0049-9

10.1007/S12325-013-0049-9

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

19 October 2017

1048008242

0 references

1 reference